Nuclear transcription factor NFκB is highly upregulated in IBC, along with overexpression of HER1 and in some cases, HER2 and HER3, and we observed a decrease in the NFκB mediator IKKα when treated with SAH5-EJ1 (Fig. 4g). This evidence concerns the gene EGFR and inflammatory breast carcinoma.